[Polyomavirus and tubulointerstitial nephropathy]

MeSH terms

• Adrenal Cortex Hormones / adverse effects
• Adrenal Cortex Hormones / therapeutic use
• Antilymphocyte Serum / adverse effects
• Antilymphocyte Serum / therapeutic use
• Antiviral Agents / therapeutic use
• BK Virus / growth & development
• BK Virus / isolation & purification*
• Diabetes Mellitus, Type 1 / complications
• Graft Rejection
• Humans
• Immunocompromised Host
• Immunosuppression Therapy / adverse effects*
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use
• Kidney Transplantation*
• Male
• Middle Aged
• Nephritis, Interstitial / drug therapy
• Nephritis, Interstitial / epidemiology
• Nephritis, Interstitial / etiology*
• Nephritis, Interstitial / pathology
• Nephritis, Interstitial / virology
• Opportunistic Infections / drug therapy
• Opportunistic Infections / etiology*
• Opportunistic Infections / pathology
• Opportunistic Infections / virology
• Polyomavirus Infections / complications*
• Polyomavirus Infections / drug therapy
• Polyomavirus Infections / epidemiology
• Polyomavirus Infections / pathology
• Postoperative Complications / drug therapy
• Postoperative Complications / etiology*
• Postoperative Complications / pathology
• Postoperative Complications / virology
• Risk Factors
• T-Lymphocytes
• Virus Activation